TotalMarketCap

Adicet Bio

ACETNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$27.616 M

$2.95 -4.84%

Close of 6 Nov 2026

As of 6 Nov 2026, Adicet Bio (ACET) has a market capitalization of $27.6M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$116.8M

Loss-making

Shares outstanding

9,361,596

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #366Incannex HealthcareIXHL$28.6M
  2. #367Annovis BioANVS$28.1M
  3. #368Adicet BioACET$27.6M
  4. #369BeyondSpringBYSI$26.6M
  5. #370Abvc BiopharmaABVC$26.3M

What if Adicet Bio were worth as much as…

Open the what-if tool →

Gold $28.2T

$3,016,280

Per share 1,022,468× higher

Bitcoin $1.53T

$163,205.65

Per share 55,324× higher

Apple $5.02T

$535,788.91

Per share 181,623× higher

Or at a round number

$50.0M$100.0M$200.0M$500.0M

Where these numbers come from

Share counts and financials for Adicet Bio are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.